Uptake of isoniazid preventive therapy among under-five children: TB contact investigation as an entry point

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Tadesse, Yared ^a   Gebre, Nigussie ^b   Daba, Shallo ^c   Gashu, Zewdu ^a   Habte, Dereje ^a   Hiruy, Nebiyu ^a   Negash, Solomon ^a   Melkieneh, Kassahun ^a   Jerene, Degu ^a   Haile, Yared K ^d   Kassie, Yewulsew ^d   Melese, Muluken ^a   Suarez, Pedro G ^e  

^a Management Sciences for Health   (Ethiopia)

^b Amhara Regional Health Bureau   (Ethiopia)

^c Oromia Regional Health Bureau   (Ethiopia)

^d UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^e MANAGEMENT SCIENCES FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ETHIOPIA; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE PRACTICE; HEALTH PROGRAM; HOUSEHOLD; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PREVENTIVE MEDICINE; SCREENING; SMEAR; TREATMENT DURATION; TREATMENT RESPONSE; ALGORITHM; COMMUNICABLE DISEASE CONTROL; CONTACT EXAMINATION; INFANT; INFORMATION PROCESSING; RISK; TRANSMISSION; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

ALGORITHMS; ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; CONTACT TRACING; DATA COLLECTION; ETHIOPIA; HUMANS; INFANT; ISONIAZID; RISK; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84982171436     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155525     Document Type: Article

References (35)

1. World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization; 2015. Available: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059-eng.pdf?ua=1
2. World Health Organization. Gear up to end TB: Introducing the WHO End TB Strategy. Geneva: World Health Organization; 2015. Available: http://www.who.int/tb/End-TB-brochure.pdf?ua=1.
3. World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015: report by the Secretariat. Geneva: World Health Organization; 2013. Available: http://apps.who.int/gb/ebwha/pdf-files/EB134/B134-12-en.pdf?ua=1.
4. Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children. a meta - analysis. BMC Infectious Diseases 2014; 14:91. doi: 10.1186/1471-2334-14-91 PMID: 24555539
5. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization; 2014. Available: http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748-eng.pdf?ua=.
6. th ed. Addis Ababa: Federal Ministry of Health; April 2012. Available: http://www.etharc.org/resources/download/finish/33/709.
7. Costenaro P, Massavon W, Lundin R, Nabachwa SM, Fregonese F, Morelli E, et al. Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience. J Acquir Immune Defic Syndr. 2016; 71 (1):e1-e8. PMID: 26761275
8. Triasih R, Robertson CF, Duke T, Graham SM. A Prospective Evaluation of the Symptom-Based Screening Approach to the Management of Children Who Are Contacts of Tuberculosis Cases. Clinical Infectious Diseases 2015; 60 (1):12-8. doi: 10.1093/cid/ciu748 PMID: 25270649
9. Hall C, Sukijthamapan P, Santos R, Nourse C, Murphy D, Gibbons M, et al. Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor Leste. Trop Med Int Health. 2015; 20 (6):730-6. doi: 10.1111/tmi.12479 PMID: 25682846
10. Van Wyk SS, Hamade H, Hesseling AC, Beyers N, Enarson DA, Mandalakas AM. Recording isoniazid preventive therapy delivery to children: operational challenges. Int J Tuberc Lung Dis. 2010; 14(5):650-653. PMID: 20392361
11. Osman M, Hesseling AC, Beyers N, Enarson DA, Rusen ID, Lombard C, et al. Routine programmatic delivery of isoniazid preventive therapy to children in Cape Town, South Africa. Public health action. 2013; 3(3):199-203. PMID: 26393029
12. Shivaramakrishna HR, Frederick A, Shazia A, Murali L, Satyanarayana S, Nair SA, et al. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis. 2014; 18(8): 919-924. doi: 10.5588/ijtld.14.0072 PMID: 25199005
13. Federal Ministry of Health. Annual TB Bulletin 2015. Addis Ababa, 2015.
14. Jerene D, Melese M, Kassie Y, Alem G, Daba SH, Hiruye N, et al. The yield of tuberculosis household contact investigation in two regions of Ethiopia. Int J Tuberc Lung Dis. 2015; 19: 898-903. doi: 10.5588/ijtld.14.0978 PMID: 26162354
15. Lester R, Hamilton R, Charalambous S, Dwadwa T, Chandler C, Churchyard GJ, et al. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS. 2010; 24: S45-48.
16. Getahun H, Granich R, Sculier D, Gunneberg E, Blanc L, Nunn P, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS. 2010; 24: S57-65. doi: 10.1097/01.aids.0000391023.03037.1f PMID: 21079430
17. Schaaf HS, Marais BJ, Whitelaw A, Hesseling AC, Eley B, Hussey GD, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis. 2007; 7 (1): 140.
18. Claessens NJ, Gwesi F, Meijnen S, Weismuller M, Salaniponi F, Harries AD. Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis. 2002; 6: 362-364. PMID: 11936747
19. Yirdaw KD, Jerene D, Gashu Z, Edginton ME, Kumar AMV, Letamo Y, et al. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PLoS One 2014; 9: e104557. doi: 10.1371/journal.pone.0104557 PMID: 25105417
20. Assefa D, Klinkenberg E, Yosef G. Cross sectional study evaluating routine contact investigation in Addis Ababa, Ethiopia: a missed opportunity to prevent tuberculosis in children. PLoS One 2015; 10: e0129135. doi: 10.1371/journal.pone.0129135 PMID: 26083244
21. Garie KT, Yassin MA, Cuevas LE. Lack of adherence to isoniazid chemoprophylaxis in children in contact with adults with tuberculosis in southern Ethiopia. PLoS One. 2011; 6 (11): e26452. doi: 10.1371/journal.pone.0026452 PMID: 22069451
22. Jafri R, Abdul Malik A, Hussain H, Hussain S, Khatoon F, Asif K, et al. IPT uptake among child contacts of TB patients: experience from the Indus Hospital TB program, Karachi, Pakistan. Int J Mycobacteriol. 2015; 4: 104-105.http://ac.els-cdn.com/S2212553114002052/1-s2.0-S2212553114002052-main.pdf?-tid=69d17aa0-7827-11e5-bc7c-00000aacb362&acdnat=1445454817-61749774b1912ba33601f2741a33c8b1
23. Adams LV, Olotu R, Talbot EA, Cronin BJ, Christopher R, Mkomwa Z. Ending neglect: providing effective childhood tuberculosis training for health care workers in Tanzania. Public health action. 2014; 4(4):233-237. doi: 10.5588/pha.14.0076 PMID: 26400701
24. Le Roux SM, Cotton MF, Myer L, Le Roux DM, Schaaf HS, Lombard CJ, et al. Safety of long-term isoniazid preventive therapy in children with HIV: a comparison of two dosing schedules. Int J Tuberc Lung Dis. 2013; 17 (1): 26-31. doi: 10.5588/ijtld.11.0820 PMID: 23146410
25. Donald PR. Anti-tuberculosis drug-induced hepatotoxicity in children. Pediatrics Reports. 2011; 3 (2): e16.
26. Frydenberg AR, Graham SM. Toxicity of first-line drugs for treatment of tuberculosis in children: review. Trop Med Int Health. 2009; 14 (11): 1329-1337. doi: 10.1111/j.1365-3156.2009.02375.x PMID: 19735381
27. Masini EO, Sitienei J, Weyeinga H. Outcomes of isoniazid prophylaxis among HIV-infected children attending routine HIV care in Kenya. Public Health Action. 2013; 3 (3): 204-208. doi: 10.5588/pha.13.0013 PMID: 26393030
28. USAID. Rational Pharmaceutical Management Plus. 2006-2007. Improving Tuberculosis Pharmaceutical Management with Individualized Treatment Kits: Paraguay and Bolivia Case Studies. Available: http://pdf.usaid.gov/pdf-docs/Pdaco309.pdf
29. Graham SM, Triasih R. More evidence to support screening of child contacts of tuberculosis cases: if not now, then when? Clin Infect Dis. 2013; 57: 1693-1694. doi: 10.1093/cid/cit647 PMID: 24077056
30. Gomes VF, Andersen A, Wejse C, Wejse C, Oliveira I, Vieira FJ, et al. Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau. Thorax. 2011; 66: 163-167. doi: 10.1136/thx.2010.141309 PMID: 21148136
31. Du Preez K, Hesseling AC, Mandalakas AM, Marais BJ, Schaaf HS. Opportunities for chemoprophylaxis in children with culture-confirmed tuberculosis. Ann Trop Paediatr. 2011; 31(4): 301-310. doi: 10.1179/1465328111Y.0000000035 PMID: 22041464
32. Nyirenda M, Sinfield R, Haves S, Molyneux EM, Graham SM. Poor attendance at a child TB clinic in Malawi. Int J Tuberc Lung Dis. 2006; 10: 585-587. PMID: 16704044
33. Van Soelen N, Du Preez K, Van Wyk SS, Mandalakas AM, Enarson DA, Reid JA, et al. Does an Isoniazid Prophylaxis Register Improve Tuberculosis Contact Management in South African Children? PLoS One. 2013; 8(12): e80803. doi: 10.1371/journal.pone.0080803 PMID: 24339884
34. Smieja M, Marchetti C, Cook D, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000; 2: CD001363. PMID: 10796642
35. Rieder HL. Interventions for tuberculosis control and elimination. Paris: International Union Against Tuberculosis and Lung Disease; 2002. Available: http://www.theunion.org/what we do/publications/english/pub-interventions-eng.pdf.